EARLIER IDENTIFICATION AND EARLY INTERVENTION FOR CHILDREN WHO ARE DEAF OR HARD OF HEARING
With
Professor Greg Leigh AO, Director
NextSense Institute, Australia &
Conjoint Professor, Macquarie School of Education
Macquarie University, Sydney
RESEARCHER PROFILE
Filmed in Sydney, Australia | June 2025
As Director of NextSense Institute, Professor Leigh is responsible for leading the not-for-profit organisation’s world-class research and education programs and facilities.
Professor Leigh held a variety of positions in the education of children who are deaf or hard of hearing before entering academia. He holds a degree in Special Education from Griffith University, a Master of Science (Speech and Hearing) from Washington University and a PhD in Special Education from Monash University. In 2001, he was made a Fellow of the Australian College of Educators and in 2014, he was invested as an Officer in the Order of Australia (AO) for distinguished services to the deaf and hard of hearing community.
He is a member of the Editorial Board of The Journal of Deaf Studies and Deaf Education and has researched widely on issues related to the early development and education of children who are deaf or hard of hearing.
A former National President of the Education Commission for the World Congress of the World Federation of the Deaf, Professor Leigh has also Chaired the International Steering Committees of both the Asia-Pacific Congress on Deafness (APCD) and the International Congress on Education of the Deaf (ICED).
He has served on several Australian Government consultative committees, including the New South Wales Ministerial Standing Committee on Hearing, the National Neonatal Hearing Screening Working Party, and the Key Scientists Committee of the Hearing Cooperative Research Centre.
For the last 19 years, Professor Leigh has chaired the Australasian Newborn Hearing Screening Committee.
In his spare time, Professor Leigh is an active member/supporter of the Sydney Swans Football Club, and he and his wife enjoy symphonic music. He is also actively involved in the work of the St Vincent de Paul Society as a volunteer for the Vinnie’s Van program.
Source: Supplied
-
Digital Biomarkers and AI for Optimal Diagnosis, Treatment, and Decision-Making
Associate Professor Johan Verjans is a clinician-scientist with a strong focus on cross-disciplinary translational research. In his role as Deputy Director at the Australian Institute for Machine Learning (AIML)—one of the world’s premier machine learning institutes, with over 200 researchers—and as Group Leader of Artificial Intelligence at the South Australian Health and Medical Research Institute (SAHMRI), he integrates his expertise in molecular medicine, clinical research, and advanced imaging with machine learning applications. This unique combination enables him to drive the translation of cutting-edge AI research into practical medical applications. He works with global teams from multinationals on AI problems.
-
Targeting chemotherapy resistance in ovarian cancer patients
Dr Alex Cole, from the Centenary Institute’s Centre for Biomedical AI, is now leading the research focused on developing a new treatment to counteract a protein called follistatin (FST), known for making ovarian cancer cells resistant to chemotherapy.
By employing cutting-edge molecular biology and directed evolution techniques, the project aims to create nanobodies—small, precise molecules—that can block FST. If successful, these nanobodies could enhance the effectiveness of chemotherapy and improve ovarian cancer treatment rates.
-
New models of care and value in General Practice
Dr Michael Wright is a GP, health economist and health services researcher. Dr Wright currently works as a portfolio GP, combining clinical practice with strategic appointments (most recently with RACGP, Central and Eastern Sydney Primary Health Network, Avant Mutual the Australian Institute of Health and Welfare) and academic research analysing the effects of current health policy on the quality and performance of primary care.
